Literature DB >> 9516679

Diagnosis of porphyric syndromes: a practical approach in the era of molecular biology.

H L Bonkovsky1, G F Barnard.   

Abstract

For cost-effective diagnosis of porphyric syndromes, a logical stepwise approach is best. If neurovisceral features suggest an acute porphyric syndrome, a rapid screening test for urinary porphobilinogen should be performed. If clinical features suggest a cutaneous porphyria, then for solar urticaria and acute photosensitivity (suggesting protoporphyria) screening tests for increased erythrocytic porphyrins should be done; for vesiculobullous formation (suggesting porphyria cutanea tarda, hereditary coproporphyria, or variegate porphyria) a screening test for urinary porphyrins should be done. Positive screening tests should be confirmed with targeted quantitative testing. Enzymatic assays and DNA-based testing are not usually needed for rapid diagnosis or management of symptomatic subjects, but they are useful for kindred evaluation and genetic counseling.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9516679     DOI: 10.1055/s-2007-1007141

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  7 in total

Review 1.  ACP Best Practice No 165: front line tests for the investigation of suspected porphyria.

Authors:  A C Deacon; G H Elder
Journal:  J Clin Pathol       Date:  2001-07       Impact factor: 3.411

2.  The acute porphyrias: a diagnostic and therapeutic challenge in internal and emergency medicine.

Authors:  Paolo Ventura; Maria Domenica Cappellini; Emilio Rocchi
Journal:  Intern Emerg Med       Date:  2009-05-29       Impact factor: 3.397

3.  Feline acute intermittent porphyria: a phenocopy masquerading as an erythropoietic porphyria due to dominant and recessive hydroxymethylbilane synthase mutations.

Authors:  Sonia Clavero; David F Bishop; Mark E Haskins; Urs Giger; Raili Kauppinen; Robert J Desnick
Journal:  Hum Mol Genet       Date:  2009-11-24       Impact factor: 6.150

4.  Is screening for urinary porphobilinogen useful among patients with acute polyneuropathy or encephalopathy?

Authors:  Elena Pischik; Valery Kazakov; Raili Kauppinen
Journal:  J Neurol       Date:  2008-06-27       Impact factor: 4.849

5.  The Porphyrias.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  2000-12

Review 6.  Clinically important features of porphyrin and heme metabolism and the porphyrias.

Authors:  Siddesh Besur; Wehong Hou; Paul Schmeltzer; Herbert L Bonkovsky
Journal:  Metabolites       Date:  2014-11-03

Review 7.  An update of clinical management of acute intermittent porphyria.

Authors:  Elena Pischik; Raili Kauppinen
Journal:  Appl Clin Genet       Date:  2015-09-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.